SIG Combibloc Group AG (0P4G)
London Exchange · UK · prices in GBP · close of 22 Oct 2026
Key indicators
| Last close | GBP 24.60 |
|---|---|
| 52-week range | 8.02 – 24.60 |
| Return, 1 month / 3 months | +82.8% / +0.0% |
| Return, 1 year / 3 years | +0.0% / +26.1% |
| Trend | Uptrend |
| RSI (14) | 55 |
| Volatility (1 year) | 714.6% |
| Worst drawdown (1 year) | -66.4% |
| Average daily value traded | 3.97M GBP |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
SIG Combibloc Group supplies aseptic carton packaging and the filling machines that use it, mainly for drinks and liquid foods such as milk, juice and plant-based products. The company serves food and beverage producers around the world, offering carton packs, filling equipment, closures and related service and spare parts. It is based in Neuhausen am Rheinfall, Switzerland, and operates across many countries, working with both large and smaller producers who need shelf-stable packaging for their products.
SIG Combibloc Group AG trades under the code 0P4G on the London Exchange in UK, with its price quoted in pounds sterling (GBP). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
SIG Combibloc Group AG (0P4G) trades on the London Exchange in UK. It last closed at GBP 24.60 on 22 October 2026.
Its price-based Market X-Ray is 44 out of 100 (a weak price profile), ranking 2,391 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 0.0% and over the last three months it rose 0.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 79 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 22.8% | ||
| From 52-week high | 0.0% | ||
| Momentum | 37 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 0.0% | ||
| 6-month return | 0.0% | ||
| 12-month return, skipping the last month | -45.3% | ||
| Stability (higher is calmer) | 5 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 714.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -66.4% | ||
| Liquidity | 66 · Fair | Moderate trading activity. | |
| Average daily value traded | 3.97M GBP | ||
| Zero-volume days | 6.7% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 4 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +76.2% |
|---|---|
| 1 month | +82.8% |
| 3 months | +0.0% |
| 6 months | +0.0% |
| 1 year | +0.0% |
| 3 years | +26.1% |
| 5 years | – |
Signals
| 50-day / 200-day average | 20.13 / 20.04 |
|---|---|
| Golden / death cross (60 days) | Golden, 1 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 8.77 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 11 Apr 2025 | GBX 0.0049 |
| 26 Apr 2024 | GBX 0.0048 |
| 25 Apr 2023 | GBX 0.0047 |
| 12 Apr 2022 | GBX 0.0045 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.